Literature DB >> 27278790

Noncoding RNA and colorectal cancer: its epigenetic role.

Yoshiaki Kita1, Keiichi Yonemori1, Yusaku Osako1, Kenji Baba1, Shinichiro Mori1, Kosei Maemura1, Shoji Natsugoe1.   

Abstract

The use of novel sequencing and high-throughput techniques has become widespread, and are now readily available to obtain the comprehensive transcription profile of the human genome. Noncoding RNAs (ncRNAs) are transcripts that have no apparent protein-coding capacity, but they have important roles in human physiology. Most research in this area has focused on micro-RNAs. However, the role of long ncRNAs (lncRNAs) as drivers of tumor suppression and oncogenic functions has recently been examined in numerous cancer types. Epigenetic alterations can reportedly deregulate the expression of any type of transcript. However, the exact mechanisms of epigenetic regulation of lncRNA are still unknown. In this review, the authors primarily focus on the epigenetic effects modulating ncRNA in colorectal cancer (CRC). The authors specifically discuss examples of oncogenic ncRNA in CRC pathobiology, as well as its extended diagnosis, prognosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27278790     DOI: 10.1038/jhg.2016.66

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  96 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.

Authors:  Constance Baer; Rainer Claus; Lukas P Frenzel; Manuela Zucknick; Yoon Jung Park; Lei Gu; Dieter Weichenhan; Martina Fischer; Christian Philipp Pallasch; Esther Herpel; Michael Rehli; John C Byrd; Clemens-Martin Wendtner; Christoph Plass
Journal:  Cancer Res       Date:  2012-06-18       Impact factor: 12.701

Review 3.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

Authors:  Yue Chen; Yongxi Song; Zhenning Wang; Zhenyu Yue; Huimian Xu; Chengzhong Xing; Zhuangkai Liu
Journal:  J Gastrointest Surg       Date:  2010-04-27       Impact factor: 3.452

6.  Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.

Authors:  Marco Ragusa; Alessandra Majorana; Luisa Statello; Marco Maugeri; Loredana Salito; Davide Barbagallo; Maria Rosa Guglielmino; Laura R Duro; Rosario Angelica; Rosario Caltabiano; Antonio Biondi; Maria Di Vita; Giuseppe Privitera; Marina Scalia; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Francesco Basile; Cinzia Di Pietro; Michele Purrello
Journal:  Mol Cancer Ther       Date:  2010-09-29       Impact factor: 6.261

7.  The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

Authors:  Bodo Brueckner; Carlo Stresemann; Ruprecht Kuner; Cora Mund; Tanja Musch; Michael Meister; Holger Sültmann; Frank Lyko
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

9.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

10.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more
  24 in total

1.  LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.

Authors:  La-Mei Zhang; Ping Wang; Xiao-Min Liu; Ying-Jian Zhang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.

Authors:  Juan Li; Yifan Lian; Changsheng Yan; Zeling Cai; Jie Ding; Zhonghua Ma; Peng Peng; Keming Wang
Journal:  Cell Prolif       Date:  2016-10-27       Impact factor: 6.831

3.  Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.

Authors:  Sho Sugawara; Yasutaka Yamada; Takayuki Arai; Atsushi Okato; Tetsuya Idichi; Mayuko Kato; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2018-03-14       Impact factor: 3.172

Review 4.  Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.

Authors:  K M Marks; N P West; E Morris; P Quirke
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

5.  A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer.

Authors:  Yifan Lian; Changsheng Yan; Jie Ding; Rui Xia; Zhonghua Ma; Bingqing Hui; Hao Ji; Jing Zhou; Keming Wang
Journal:  Oncotarget       Date:  2017-07-31

6.  Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.

Authors:  Jiang-Hui Zeng; Liang Liang; Rong-Quan He; Rui-Xue Tang; Xiao-Yong Cai; Jun-Qiang Chen; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-03-07

Review 7.  Epigenetics of colorectal cancer: biomarker and therapeutic potential.

Authors:  Gerhard Jung; Eva Hernández-Illán; Leticia Moreira; Francesc Balaguer; Ajay Goel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-01-03       Impact factor: 46.802

8.  Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer.

Authors:  Cong Li; Li Zhou; Jun He; Xue-Qing Fang; Shao-Wen Zhu; Mao-Ming Xiong
Journal:  BMC Cancer       Date:  2016-08-19       Impact factor: 4.430

9.  Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.

Authors:  Yuping Zhu; Bo Li; Zhuo Liu; Lai Jiang; Gang Wang; Min Lv; Dechuan Li
Journal:  Oncotarget       Date:  2017-12-04

10.  Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.

Authors:  Tetsuya Idichi; Naohiko Seki; Hiroshi Kurahara; Keiichi Yonemori; Yusaku Osako; Takayuki Arai; Atsushi Okato; Yoshiaki Kita; Takaaki Arigami; Yuko Mataki; Yuko Kijima; Kosei Maemura; Shoji Natsugoe
Journal:  Oncotarget       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.